CSN Login
Members Online: 3

You are here

CSN Home › Discussion boards › Cancer specific › Colorectal Cancer

New Study for K-Ras Stage IV : Enroll THIS WEEK!

dianetavegia's picture
dianetavegia
Posts: 1953
Joined: Mar 2009
Aug 09, 2009 - 10:59 am

Click Here for full article

The open-label, 56-patient KRAS-mutated colorectal cancer study is being conducted at three U.S. locations. Patient enrollment begins this week. All subjects will receive Imprime PGG® at 4 mg/kg weekly plus standard doses of Erbitux®. Tumor measurements and determination of tumor responses for this study will be performed according to Response Evaluation Criteria in Solid Tumors (RECIST).
Subscribe to Comments for "New Study for K-Ras Stage IV : Enroll THIS WEEK!"

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2019 © Cancer Survivors Network